Hypertrophic cardiomyopathy is a genetic disorder characterized by marked hypertrophy of
the myocardium. It is frequently accompanied by dynamic left ventricular outflow tract …

Risk for Permanent Pacemaker After Transcatheter Aortic Valve Implantation. Background:
Permanent pacemaker (PM) requirement is a known complication after transcatheter aortic …

Aims The first cases of alcohol septal ablation (ASA) for obstructive hypertrophic
cardiomyopathy (HCM) were published two decades ago. Although the outcomes of single …

After 50 years of recognition and study, it is evident that hypertrophic cardiomyopathy (HCM)
is a particularly heterogeneous and unpredictable disease with respect to its clinical …

Background: Alcohol-induced infarction for treatment of symptomatic hypertrophic
obstructive cardiomyopathy (HOCM) was discussed as a risk factor for increased cardiac …

Background—The impact of alcohol septal ablation (ASA)-induced scar is not known. This
study sought to examine the long-term outcome of ASA among patients with obstructive …

Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy
have been going head‐to‐head for the past 20 years with similar outcomes and mortality …

Objectives: The aim of this study was to compare the survival of patients with hypertrophic
cardiomyopathy (HCM) and resting left ventricular outflow tract (LVOT) obstruction managed …

Aims Our purpose is to conduct a meta-analysis of all published studies comparing alcohol
septal ablation (ASA) and myectomy (MM) for drug refractory hypertrophic obstructive …

Systolic anterior motion (SAM) of the mitral valve (MV) can be a life-threatening condition.
The SAM can result in severe left ventricular outflow tract obstruction and/or mitral …